Please use this identifier to cite or link to this item:
Authors: Peiris, Sasha
Ordunez, Pedro
DiPette, Donald
Padwal, Raj
Ambrosi, Pierre
Toledo, Joao
Stanford, Victoria
Lisboa, Thiago
Aldighieri, Sylvain
Reveiz, Ludovic
Title: Cardiac Manifestations in Patients with COVID-19: A Scoping Review.
Keywords: COVID-19;Heart;Complications;Heart Diseases;Review
Issue Date: 2022
Publisher: Global Heart
Citation: LISBOA, T. C. et al. Cardiac Manifestations in Patients with COVID-19: A Scoping Review. Global Heart, v. 17, p. 2, 2022. Disponível em: Acesso em: 17 nov. 2023
Abstract: Background: Coronavirus disease 2019 (COVID-19), commonly affects the lungs, but the involvement of other organs, particularly the heart, is highly prevalent as has been reported in several studies. The overall aim of this review was to provide an in-depth description of the available literature related to the cardiac system and COVID-19 infection. It focuses on type and the frequency of cardiac manifestations, clinical parameters and cardiac biomarkers that support the prognosis of COVID-19 patients, and the cardiac adverse events and outcomes related to pharmacotherapy. Methods: A scoping review was conducted searching Embase, PubMed, Epistomonikos, Medrxiv, BioRxiv databases, up to November 2020, for systematic reviews relevant to cardiac manifestations in adult COVID-19 patients. Relevant articles were screened and extracted to summarize key outcomes and findings. Results: A total of 63 systematic reviews met the inclusion criteria. The overall frequency of acute cardiac injury ranged from 15% to 33% in the reporting studies. The main cardiac complications were arrhythmias (3.1% to 6.9% in non-severe patients, 33.0% to 48.0% in severe disease), acute coronary syndromes (6% to 33% in severe disease), and myocarditis. Most studies found no association with the use of Reninangiotensin-aldosterone system inhibitors (RAASI) with COVID-19 outcomes such as susceptibility to infection, hospitalization, severity, and mortality. Conclusion: This study provided an overview of the several cardiac complications associated with Covid-19. Cardiac injury, arrhythmias, myocarditis, cardiac failure, and acute coronary syndrome, are prevalent and clinically significant and associated with COVID-19 disease severity and mortality. Other studies are needed to clearly identify what is the part of viral heart infection and what is the part of cardiac injury secondary to acute respiratory failure and inflammation. In the therapeutic field, these systematic reviews gave heterogenous results. This underlines the importance of randomized trials to determine the right therapeutic approach.
Appears in Collections:Artigo de Periódico (Educação Física)

Files in This Item:
File Description SizeFormat 
tclisboa.pdfOpen Access673,22 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.